Nov 5, 2024 7:33 AM
BACK TO TOP
KSE100
91,938.00
0.00
(0.00%)
ALLSHR
58,408.13
0.00
(0.00%)
KSE30
28,743.73
0.00
(0.00%)
KMI30
140,200.81
0.00
(0.00%)
BKTI
21,879.55
0.00
(0.00%)
OGTI
22,260.12
0.00
(0.00%)
KMIALLSHR
40,251.54
0.00
(0.00%)
PSXDIV20
35,591.48
0.00
(0.00%)
UPP9
27,891.41
0.00
(0.00%)
NITPGI
22,300.60
0.00
(0.00%)
NBPPGI
25,068.59
0.00
(0.00%)
MZNPI
18,522.79
0.00
(0.00%)
JSMFI
26,148.10
0.00
(0.00%)
ACI
14,667.20
0.00
(0.00%)
JSGBKTI
24,481.97
0.00
(0.00%)
MII30
13,135.42
0.00
(0.00%)
HBLTTI
15,183.43
01-11-2024
8.25
(0.05%)
Citi Pharma Ltd.
XD
PHARMACEUTICALS
Rs.40.81
-0.16
(-0.39%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, Nov 4, 2024 4:14 PM
REG
FUT
ODL
Open
41.10
High
41.40
Low
40.69
Volume
1,595,924
CIRCUIT BREAKER
36.73 — 44.89
DAY RANGE
40.69 — 41.40
52-WEEK RANGE
20.01 — 46.90
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
40.81
VAR
11.50
HAIRCUT
15.00
P/E Ratio (TTM) **
9.91
1-Year Change *
69.90%
YTD Change *
71.90%
Last update: Mon, Nov 4, 2024 4:00 PM
Open
41.70
High
41.79
Low
41.10
Close
41.19
Change
-0.60%
LDCP
41.19
Volume
388,500
Total Trades
165
CIRCUIT BREAKER
37.07 — 45.31
DAY RANGE
41.10 — 41.79
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Thu, Oct 10, 2024 3:19 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
42.06
Volume
0
Total Trades
0
CIRCUIT BREAKER
37.85 — 46.27
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Ghulam DastgeerCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Equity Profile

Market Cap (000's)
9,323,501.57
Shares
228,461,200
Free Float
79,961,420
Free Float
35.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 31, 2024Transmission of Quarterly Report for the Period Ended View   PDF
Oct 30, 2024Transmission of Quarterly Report for the Period Ended
REVOKED
View   PDF
Oct 30, 2024Financial Results for the Quarter Ended View   PDF
Oct 9, 2024Transmission of Annual Report for the Year Ended View   PDF
Oct 2, 2024Financial Results for the year ended View   PDF
Apr 30, 2024Transmission of Quarterly Report for the period ended View   PDF
Apr 26, 2024Financial Results for the quarter ended View   PDF
Mar 4, 2024Transmission of Quarterly Report for Period Ended View   PDF
Feb 29, 2024Financial Results for the Quarter Ended 2023-12-31 View   PDF
Oct 31, 2023Transmission of Quarterly Report for the Period Ended September 30, 2023 View   PDF
DateTitleDocument
Oct 30, 2024Board Meeting in Progress View   
Oct 23, 2024Board Meeting View   
Oct 7, 2024Notice of Annual General Meeting View   PDF
Oct 1, 2024Board Meeting in Progress View   
Sep 23, 2024Board Meeting View   
Apr 25, 2024Board Meeting in Progress View   
Apr 18, 2024Board Meeting View   
Feb 21, 2024Board Meeting View   
Oct 20, 2023Board Meeting View   
Oct 6, 2023Notice of Annual General Meeting View   PDF
DateTitleDocument
Nov 1, 2024Annual Free Float Certificate Duly Verified by Auditor View   PDF
Oct 11, 2024Material Information View   PDF
Sep 20, 2024Material Information View   PDF
Jul 5, 2024Company Secretary View   
Jul 2, 2024Material Information View   PDF
May 15, 2024Material Information View   PDF
May 7, 2024Change of Company Secretary View   
May 7, 2024Material Information View   PDF
Nov 13, 2023Dispatch of Final Dividend Warrants View   PDF
Nov 8, 2023Material Information View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales12,409,23912,396,9839,779,8805,795,404
Profit after Taxation833,464657,984635,884351,768
EPS3.652.882.883.64
Q1 2025Q3 2024Q2 2024Q1 2024
Sales3,224,6453,558,8743,275,1652,701,228
Profit after Taxation201,497211,345375,60194,452
EPS0.880.931.640.41
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
Gross Profit Margin (%)12.7812.1613.8313.47
Net Profit Margin (%)6.725.316.506.07
EPS Growth (%)26.74(20.88)(88.58)
PEG0.29(0.54)(0.11)

Payouts

DateFinancial ResultsDetailsBook Closure
October 2, 2024 2:52 PM30/06/2024(YR) 32.50%(F) (D) 21/10/2024 - 28/10/2024
September 28, 2023 4:07 PM30/06/2023(YR) 25%(F) (D) 20/10/2023 - 27/10/2023
September 30, 2021 9:32 PM30/06/2021(YR) 15% (D) - 10% (B) 21/10/2021 - 28/10/2021

Financial Reports